Gemtuzumab Ozogamicin Ozogamicin represents a unique development in the management of relapsed blood disease, mainly severe leukemic leukemia (AML). This antibody-drug joins a engineered immunoglobulin directed for https://www.targetmol.com/compound/gemtuzumab